265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients

Detalles Bibliográficos
Autores principales: Pakhchanian, H., Raiker, R., Jenkins, K., Shen, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296913/
http://dx.doi.org/10.1016/j.jid.2022.05.272
_version_ 1784750365991763968
author Pakhchanian, H.
Raiker, R.
Jenkins, K.
Shen, L.
author_facet Pakhchanian, H.
Raiker, R.
Jenkins, K.
Shen, L.
author_sort Pakhchanian, H.
collection PubMed
description
format Online
Article
Text
id pubmed-9296913
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92969132022-07-20 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients Pakhchanian, H. Raiker, R. Jenkins, K. Shen, L. J Invest Dermatol Article Published by Elsevier Inc. 2022-08 2022-07-20 /pmc/articles/PMC9296913/ http://dx.doi.org/10.1016/j.jid.2022.05.272 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pakhchanian, H.
Raiker, R.
Jenkins, K.
Shen, L.
265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title_full 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title_fullStr 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title_full_unstemmed 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title_short 265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
title_sort 265 evaluating the safety and effectiveness of the covid-19 vaccination among pediatric atopic dermatitis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296913/
http://dx.doi.org/10.1016/j.jid.2022.05.272
work_keys_str_mv AT pakhchanianh 265evaluatingthesafetyandeffectivenessofthecovid19vaccinationamongpediatricatopicdermatitispatients
AT raikerr 265evaluatingthesafetyandeffectivenessofthecovid19vaccinationamongpediatricatopicdermatitispatients
AT jenkinsk 265evaluatingthesafetyandeffectivenessofthecovid19vaccinationamongpediatricatopicdermatitispatients
AT shenl 265evaluatingthesafetyandeffectivenessofthecovid19vaccinationamongpediatricatopicdermatitispatients

Ejemplares similares